1. Home
  2. AAP vs IDYA Comparison

AAP vs IDYA Comparison

Compare AAP & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Advance Auto Parts Inc.

AAP

Advance Auto Parts Inc.

HOLD

Current Price

$51.34

Market Cap

3.1B

ML Signal

HOLD

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

HOLD

Current Price

$32.34

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AAP
IDYA
Founded
1929
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Auto & Home Supply Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
2.9B
IPO Year
2002
2019

Fundamental Metrics

Financial Performance
Metric
AAP
IDYA
Price
$51.34
$32.34
Analyst Decision
Hold
Strong Buy
Analyst Count
17
16
Target Price
$53.50
$51.21
AVG Volume (30 Days)
1.4M
767.9K
Earning Date
05-21-2026
05-05-2026
Dividend Yield
1.84%
N/A
EPS Growth
113.01
61.90
EPS
0.73
N/A
Revenue
$8,601,000,000.00
$218,710,000.00
Revenue This Year
$0.43
N/A
Revenue Next Year
$2.52
$191.08
P/E Ratio
$74.40
N/A
Revenue Growth
N/A
3024.43
52 Week Low
$28.89
$13.45
52 Week High
$70.00
$39.28

Technical Indicators

Market Signals
Indicator
AAP
IDYA
Relative Strength Index (RSI) 49.31 48.96
Support Level $49.18 $29.29
Resistance Level $52.10 $34.86
Average True Range (ATR) 2.13 1.56
MACD 0.20 0.00
Stochastic Oscillator 61.64 48.90

Price Performance

Historical Comparison
AAP
IDYA

About AAP Advance Auto Parts Inc.

Advance Auto Parts is a leading auto-parts retailer in North America with more than 4,000 store and branch locations. About half of the firm's sales are geared toward the professional channel, with the remaining sales in the do-it-yourself market. Through its vast store footprint and distribution network, Advance manages thousands of stock-keeping units for various vehicle makes and models. The retailer primarily competes on inventory availability and service speed, making the operating efficiency of its hub-and-spoke distribution model critical to meeting customer needs.

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

Share on Social Networks: